Pathos
Oncology Therapeutics · Drug Discovery AI
Sponsors visas
5Open roles1 posted in 30 days
8EmployeesUS Form 5500 (plan participants) · May 2025
Lately:1 news story in 90 daysFollow changes →
Facts
as of Nov 14, 2026Pathos integrates AI technology, biological modeling, and the largest collection of oncology patient data to make clinical trials smarter and more precise.
It is hiring: 5 open roles, 1 of them posted in the last 30 days.
- Legal name
- Pathos AI, Inc.
- Headquarters
- New York, United States
- Founded
- 2022
- Employees
- 8US Form 5500 (plan participants) · May 2025
- Open roles
- 5Alion job postings
- Register numbers
- NAME pathos ai inc
- Official records
- SEC CIK 1967854
- Website
- pathos.com
As of Nov 14, 2026, Alion lists 5 open roles at Pathos. Pathos is headquartered in New York, United States. It was founded in 2022. It has raised $365M in 3 funding rounds. The latest round is Venture - Series Unknown of $283M, announced in 2025.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Legal entity active
Pathos AI, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Hiring
All open roles →Hiring steadily, with new roles every week.
AI/ML is the largest family, 25 of open roles.
1Posted in 30 days20% of open roles are fresh
20%Remote roles1 of 5
2Roles in AI40% of open roles
1Hiring offices
Can they hire you from United States?by your location
Likely
8 open roles are in your country: you apply locally, no move needed.
No posting offers visa sponsorship. Remote roles: 1.
Alion signals0-100
Demand30
Pay4
Your chance52
How badly they need people, whether they pay, how realistic getting in is.
Open roles over time−29%
Sep 7This week
Open roles a week: 7 then, 5 now
Where the openings areshare of open roles · trend
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family
Visa
Full chapter →Named in the work visa registers of United States.
United StatesUS 1
#5,755 of 8,998 sponsors
1H-1B filings in 12 months
$403kMedian offered salary
5Open roles in United States
Who they sponsor
The salary offered for each occupationVisa pass · 90 credits In the register as Pathos AI, Inc., Chicago, IL
Other sponsors in the same field
See 5 open roles Alert me
US Department of Labor · latest filing Sep 15, 2025
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
New YorkBusiest site
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| New York United States | Headquarters | 5 | Biotech, AI/ML, Security | 40% |
Source: office addresses in postings and company registers
Financials
Funding rounds, investors and revenue on record.
$365MTotal raised
Venture - Series UnknownLatest round
3Rounds and grants
Money by yearUSD, rounds and grants
Largest rounds and grants
Sources: funding announcements, grant and company registers
Tech stack
Full chapter →Technologies named in job postings at Pathos over the last 12 months, by layer, with the share of postings for each.
26Technologies in use
9Postings analysed
89/100Stack modernityAI adopter
Sign in to see how your skills match this stackSign In
Full Pathos tech stack26 technologies · by team · pay by technology · changes · similar stacks
Source: the technologies named in the company's postings and on its site
Milestones
Apr 17, 2025
Raised a round Venture round $283M · SEC Form D
Oct 24, 2024
Raised a round Venture round $62M · SEC Form D
May 23, 2023
Mar 2, 2023
New executive Eric Lefkofsky, Executive Officer, Director · SEC Form D
2022
Founded
Each milestone is dated by its source: registers, filings, the press
Newsroom
top 2%Web presenceof 133.2M domains by links, Common Crawl
Sep 112026
News · Pulse 2.0
Pathos Communications reported first-half 2026 revenue of $7.3 million, up 14% year over year, while adjusted EBITDA increased 36% to $1.7 million as the PR technology company ex…
Aug 42026
News · pharmaphorum
Pathos AI has grown its oncology pipeline by licensing a bispecific ADC from Alphamab for $125m and partnering a breast cancer drug from AstraZeneca.
Aug 42026
Blog
NEW YORK, August 3rd, 2026 (GLOBE NEWSWIRE) - Pathos AI, a clinical-stage AI and technology company advancing its own pipeline of cancer therapies, today announced a licensing ag…
Aug 42026
Blog
Pathos assumes responsibility for early clinical development of AZD4241, utilizing its AI-driven Foundry platform to drive patient stratification and trial design.…
May 62026
May 16, 20252025
Sources: the outlets named on each headline, each story once